PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsAcrisorcin
Acrisorcin
Akrinol (acrisorcin) is a small molecule pharmaceutical. Acrisorcin was first approved as Akrinol on 1982-01-01.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Acrisorcin
Tradename
Company
Number
Date
Products
AKRINOLMerck & CoN-012470 DISCN1982-01-01
1 products
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
No data
Drug
General
Drug common nameAcrisorcin
INNacrisorcin
Description
Acrisorcin is a topical anti-infective typically used as a fungicide. It is a combination of the active ingredients 9-aminoacridine and 4-hexylresorcinol.
Classification
Small molecule
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CCCCCCc1ccc(O)cc1O.Nc1c2ccccc2nc2ccccc12
Identifiers
PDB
CAS-ID7527-91-5
RxCUI
ChEMBL IDCHEMBL1201038
ChEBI ID
PubChem CID24144
DrugBank
UNII ID2U918O4BEV (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 19 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use